Health Care Operations in the Postpandemic World

There is a very wide spectrum of potential outcomes over the medium term, and the right responses will vary depending on a company’s context and product segment—including generics, orthopedic medicines, personal protective equipment, life-saving biologics, and others. Weakened economies would likely...

Full description

Saved in:
Bibliographic Details
Published inBCG Insights
Main Authors Snyder, Aaron, Garro, Andres, Birdsey, Laurence, Aylor, Ben, Ehrhardt, Marcus, Brocca, Michele, Stanczyk, Alex
Format Web Resource
LanguageEnglish
Published Boston Boston Consulting Group Boston, MA 07.07.2020
Subjects
Coronaviruses
COVID-19
Leadership
Market positioning
Pandemics
Protectionism
Strategic planning
Suppliers
Supply chains
Online AccessGet full text

Cover

More Information
Summary:There is a very wide spectrum of potential outcomes over the medium term, and the right responses will vary depending on a company’s context and product segment—including generics, orthopedic medicines, personal protective equipment, life-saving biologics, and others. Weakened economies would likely lead to pricing pressure and changes in care delivery (such as an increase in virtual interactions with patients and a decrease in elective procedures and visits). [...]the combination of a contained virus and coherent, effective government policies could fuel a strong recovery centered on innovation. [...]medtech and biopharma companies should accelerate their investments in digital and supply chain capabilities, particularly those linked to predicting, identifying, and responding to disruptions in the most efficient and effective way.